Abeona Therapeutics (ABEO) Metrics: History & Chart

Abeona Therapeutics Inc.(ABEO)

Biotechnology · Cleveland, OH

$5.01-0.10 (-1.96%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.

Cleveland, OH

226 employees

www.abeonatherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Vishwas Seshadri

View full financials

Third-Party DCF Estimate (FMP)	$1.00
Price Gap vs Third-Party Estimate	-80.50%

7D Total Return	-3.40%
30D Total Return	-14.83%
YTD Total Return	-3.04%
1Y Total Return	-5.55%
3Y Total Return	+18.84%
5Y Total Return	-78.49%
10Y Total Return	-96.94%
15Y Total Return	-99.78%
20Y Total Return	-99.66%

2026	-3.04%
2025	-5.39%
2024	+11.18%
2023	+62.64%
2022	-63.75%
2021	-78.35%
2020

CAGR TTM	-5.53%
CAGR 3Y	+5.92%
CAGR 5Y	-26.46%
CAGR 10Y	-29.45%
CAGR 15Y	-33.50%
CAGR 20Y	-24.73%

PE Ratio	6.65
PE Ratio Avg TTM	6.29
PE Ratio Avg 3Y	6.29
Current VS TTM Avg	+5.74%
Current VS 3Y Avg	+5.74%
Current VS 5Y Avg	+5.74%

All Metrics

ABEO Valuation Metrics

ABEO Stock Price Metrics

ABEO Dividend Metrics

ABEO Growth Rate Metrics

ABEO Discounted Cash Flow Metrics

ABEO Returns By Period

ABEO Yearly Returns

ABEO Average Annual Returns By Period (CAGR)

ABEO Revenue Metrics

ABEO PE Ratio Metrics

ABEO PS Ratio Metrics

ABEO PB Ratio Metrics

ABEO Price to Free Cash Flow Ratio Metrics

ABEO Debt to Equity Ratio Metrics

ABEO PEG Ratio Metrics

ABEO FCF Yield

ABEO Earnings Yield

ABEO EBITDA Yield

ABEO OCF Yield

ABEO EV/EBIT Ratio Metrics

ABEO EV/EBITDA Ratio Metrics

ABEO EV/Assets Ratio Metrics

ABEO EV/Sales Ratio Metrics

ABEO Current Ratio Metrics

ABEO Quick Ratio Metrics

ABEO ROIC Metrics

ABEO Return on Assets Metrics

ABEO Return on Equity Metrics

ABEO Net Profit Margin Metrics

ABEO Gross Profit Margin Metrics

ABEO Tax Rate Metrics

PS Ratio	11.42
PS Ratio Avg TTM	341.11
PS Ratio Avg 3Y	260.22
Current VS TTM Avg	-96.65%
Current VS 3Y Avg	-95.61%
Current VS 5Y Avg	-50.79%

PB Ratio	2.28
PB Ratio Avg TTM	2.07
PB Ratio Avg 3Y	4.37
Current VS TTM Avg	+10.01%
Current VS 3Y Avg	-47.82%
Current VS 5Y Avg	-29.24%

PFCF Ratio	39.05
PFCF Ratio Avg TTM	35.44
PFCF Ratio Avg 3Y	35.44
Current VS TTM Avg	+10.20%
Current VS 3Y Avg	+10.20%
Current VS 5Y Avg	+10.20%

Debt/Equity Ratio	0.16
Debt/Equity Ratio Avg TTM	0.15
Debt/Equity Ratio Avg 3Y	0.33
Current VS TTM Avg	+2.11%
Current VS 3Y Avg	-52.80%
Current VS 5Y Avg	-50.50%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.56%
FCF Yield Avg TTM	2.69%
FCF Yield Avg 3Y	2.69%
Current VS TTM Avg	-4.67%
Current VS 3Y Avg	-4.67%
Current VS 5Y Avg	-4.67%

Earnings Yield	15.04%
Earnings Yield Avg TTM	17.53%
Earnings Yield Avg 3Y	17.53%
Current VS TTM Avg	-14.21%
Current VS 3Y Avg	-14.21%
Current VS 5Y Avg	-14.21%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	27.99
Ev/Ebitda Ratio Avg TTM	18.83
Ev/Ebitda Ratio Avg 3Y	18.83
Current VS TTM Avg	+48.64%
Current VS 3Y Avg	+48.64%
Current VS 5Y Avg	+48.64%

Ev/Assets Ratio	1.42
Ev/Assets Ratio Avg TTM	1.23
Ev/Assets Ratio Avg 3Y	1.84
Current VS TTM Avg	+15.35%
Current VS 3Y Avg	-22.82%
Current VS 5Y Avg	+1.07%

Ev/Sales Ratio	10.00
Ev/Sales Ratio Avg TTM	250.43
Ev/Sales Ratio Avg 3Y	190.32
Current VS TTM Avg	-96.01%
Current VS 3Y Avg	-94.75%
Current VS 5Y Avg	-57.15%

Current Ratio	6.63
Current Ratio Avg TTM	7.19
Current Ratio Avg 3Y	6.00
Current VS TTM Avg	-7.68%
Current VS 3Y Avg	+10.58%
Current VS 5Y Avg	+27.13%

Quick Ratio	6.40
Quick Ratio Avg TTM	7.00
Quick Ratio Avg 3Y	5.94
Current VS TTM Avg	-8.67%
Current VS 3Y Avg	+7.65%
Current VS 5Y Avg	+23.59%

ROIC	(49.76%)
ROIC Avg 3Y	(62.51%)
ROIC Avg 5Y	(69.68%)
Current VS 3Y Avg	+20.39%
Current VS 5Y Avg	+28.58%
Current VS 10Y Avg	+5.89%

ROA	(35.03%)
ROA Avg TTM	2.56%
ROA Avg 3Y	(15.73%)
Current VS TTM Avg	-1468.64%
Current VS 3Y Avg	-122.71%
Current VS 5Y Avg	-116.06%

ROE	(49.11%)
ROE Avg TTM	24.86%
ROE Avg 3Y	(114.66%)
Current VS TTM Avg	-297.52%
Current VS 3Y Avg	+57.17%
Current VS 5Y Avg	+65.63%

Net Profit Margin	(246.42%)
Net Profit Margin Avg TTM	5291.50%
Net Profit Margin Avg 3Y	(68.25%)
Current VS TTM Avg	-104.66%
Current VS 3Y Avg	-261.06%
Current VS 5Y Avg	-156.02%

Gross Profit Margin	73.68%
Gross Pft Margin Avg TTM	49.01%
Gross Pft Margin Avg 3Y	23.08%
Current VS TTM Avg	+50.32%
Current VS 3Y Avg	+219.21%
Current VS 5Y Avg	N/A

Tax Rate	12.47%
Tax Rate Avg 3Y	6.24%
Tax Rate Avg 5Y	6.24%
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	+100.00%